This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
A misleading statement appeared in the CLINICAL CARDIOLOGY "Should Prophylactic Antiarrhythmic Drug Therapy Be Used in Acute Myocardial Infarction" published in the April 9 issue of The Journal (1982;247:2019-2021). On page 2020, the first sentence under the "Recommended Administration Programs for Lidocaine" centerhead should have read as follows: "To maximize efficiency and minimize the likelihood of side effects, an understanding of the basic lidocaine pharmacology and metabolism is required."
Misleading Statement. JAMA. 1982;248(5):550. doi:10.1001/jama.1982.03330050034024
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: